N-terminal pro-B-type natriuretic peptide and vascular disease among 20,536 patients in the MRC/BHF heart protection study

Схожие документы

• N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study.
  по: Emberson, JR, и др.
  Опубликовано: (2007)
• N-BNP and vascular disease among 20,536 patients in the MRC/BHF Heart Protection Study
  по: Emberson, J, и др.
  Опубликовано: (2005)
• MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial
  по: Collins, R, и др.
  Опубликовано: (2002)
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.
  по: Heart Protection Study Collaborative Group
  Опубликовано: (2002)
• MRC/BHF Heart Protection Study - Reply
  по: Collins, R, и др.
  Опубликовано: (2002)